Table 1. Sociodemographic, clinical and diffusion tensor imaging data of all the patients.
| Age (mean±SD) | 35.98±7.92 years | |
|---|---|---|
| (min-max values) | (18‒51) | |
| Gender % (n) | ||
| Female | 84.5% (n=49) | |
| Male | 15.5% (n=9) | |
| Family history % (n) | ||
| Yes | 67.24% (n=39) | |
| No | 42.86% (n=19) | |
| Aura % (n) | ||
| Yes | 39.7% (n=23) | |
| No | 60.3% (n=35) | |
| Duration of diagnosis of migraine (mean±SD) | 7.36±7.26 years | |
| Monthly incidence of migraine (mean±SD) | 8.13±4.90 | |
| VAS score (mean±SD) | 8.87±1.20 | |
| OFC FA (mean±SD) | ||
| Right | 0.29±0.05 × 10-3 mm2/s | |
| Left | 0.30±0.05 × 10-3 mm2/s | |
| OFC ADC (mean±SD) | ||
| Right | 8.27±0.61 × 10-3 mm2/s | |
| Left | 8.14±0.54 × 103 mm2/s | |
| Medication overuse headache % (n) | ||
| Yes | 43.1% (n=25) | |
| No | 56.9% (n=33) | |
SD: standard deviation; VAS: visual analog scale; OFC: orbitofrontal cortex; FA: fractional anisotropy; ADC: apparent diffusion coefficient.